|
|
|
|
|
|
|
|
Detailed Program
|
| SUNDAY, JUNE 13, 2010 |
| All Day |
Seminar: INNOVATIONS
By Cleveland Clinic and ILSI
For Program Details Please Click Here
|
| |
| MONDAY, JUNE 14, 2010 |
| 09:00-10:00 |
Opening Ceremony
GREETINGS:
Ruti Alon, General Partner, Pitango Venture Capital, ILSI-Chairperson
ILSI-Biomed 2010 Co-Chairperson, Israel
Israel Makov, Chairman of Given Imaging, ILSI-Biomed 2010 Co-Chairperson, Israel
Binyamin (Fuad) Ben-Eliezer, Ministry of Industry, Trade and Labor, Israel
An Address By
The Honorable Mr. Shimon Peres, President of the State of Israel |
| 10:00-10:50 |
Keynote Lecture: SANOFI-AVENTIS – A PARTNER OF CHOICE IN INNOVATION
Chris Viehbacher, CEO, Sanofi-Aventis, France
(10:40-10:50) Interview by:
Francois Maisonrouge, Senior Managing Partner, Evercore Partner, USA |
| 10:50-11:40 |
Keynote Lecture: WHERE WE HAVE BEEN, WHERE WE MIGHT BE GOING
Robert Huffines, Co-Head of Global Healthcare Investment Banking, J.P.Morgan, USA |
| 11:40-12:10 |
Coffee Break |
| 12:10-14:10 |
Breakout Sessions |
| |
Company Presentations:
MEDICAL DEVICE
MCS Medical Compression Systems
Beta O2 Technologies. Ltd.
BrainsGate, Ltd.
Real Imaging, Ltd.
Nano Retina, Inc.
Glusense, Ltd.
|
Company Presentations:
BIOPHARMA
Atox Bio
Thrombotech Technologies, Ltd.
Intec Pharma
Otic Pharma
Kahr Medical, Ltd.
Aposense Ltd.
|
Seminar: DEVELOPING NEW VACCINES
Moderator: Dr. Ronald Ellis, Senior Vice President R&D, NasVax, Israel
TARGETS FOR FUTURE VACCINE DEVELOPMENT
Scott Gallichan, Director, Immunology Platform, Sanofi Pasteur, Canada
THE VALUE OF VACCINES AND BROADENING THE POTENTIAL OF VACCINATION WITH ADJUVANTS
Dr. Hugues Bogaerts, Vice President, Senior Medical Director, GlaxoSmithKline Biologicals, Belgium
NEW APPROACHES TO THERAPEUTIC VACCINES
Dr. Heather L. Davis,
Executive Director, Pfizer Global Research & Development, Vaccines Research, Canada
TRANSLATING INNOVATIONS IN VACCINE RESEARCH TO CLINICAL STUDIES OF NEW PRODUCT CANDIDATES
Dr. Sohail Ahmed, Head of Clinical Sciences Unit (Translational Medicine), Novartis Vaccines & Diagnostics, Italy |
CARDIOVASCULAR THERAPY IN THE 2020
Sponsored by Valtech Cardio Ltd.
(12:10-12:20)
OPENING REMARKS
Dr. Francesco Maisano, Dept. of Cardiovascular & Thoracic Medicine, Istituto Scientifico San Raffaele, Italy and Panel of Moderators
(12:20-12:40)
VALVE DISEASE: UNMET NEEDS AND OPTIONS FOR INNOVATION
Dr. Michael J. Mack, Director of Cardiovascular Surgery, Baylor Healthcare System, Director of Research, The Heart Hospital Baylor Plano, USA
(12:40-13:00)
CORONARY ARTERY DISEASE AND HEART FAILURE: UNMET NEEDS AND INNOVATIONS
Prof. Friedrich Wilhelm Mohr, Herzzentrum Universitaet Leipzig, Germany
(13:00-13:15)
Coffee Break
(13:15-13:35)
WHAT'S MISSING FROM AN INTERVENTIONAL CARDIOLOGIST 21ST CENTURY ARMAMENTARIUM?
David L. Brown, President and Chairman of the Medical Staff, Director of Interventional Cardiology, Co-Director Cardiovascular Research & Structural Heart Program, The Heart Hospital, Baylor Plano, USA
(13:35-14:10)
THE COMING COLLISIONS IN CARDIOLOGY AND THE OBLIGATION FOR INNOVATION
Dr. Joseph M. Smith, Chief Medical and Science Officer, West Wireless Health Institute, USA
|
| 14:10-15:10 |
Lunch Break |
| 15:10-16:00 |
Keynote Lecture:
SEEKING INNOVATION EVERYWHERE: HOW OPEN-MINDED COLLABORATION CREATES THE BEST ENVIRONMENT FOR CHANGING THE PRACTICE OF MEDICINE
Dr. Dan Zabrowski, Head of Pharma Partnering, Roche, USA
(15:50-16:00) Interview by:
Francois Maisonrouge, Senior Managing Partner, Evercore Partner, USA |
CARDIOVASCULAR THERAPY IN THE 2020 (Cont)
(15:10-15:45)
ADVANCES IN ENGINEERING AND SCIENCE AND THE DEVELOPMENT OF FUTURE IMPLANTABLE SYSTEMS
Dr. Bryant M. Moore, Vice President, External Partnerships and Technology Assessment, Medtronic Inc., USA
(15:45-16:20)
EP LAB OF THE FUTURE
Dr. Assaf Govari, Biosense Webster Ltd., Israel
(16:20-16:40)
VENTOR AS A STRATEGIC ACQUISTION TARGET: WHAT CAN BE LEARNED FROM THIS CASE?
Dr. Guy Ezekiel, General Manager & Vice President, Medtronic Ventor Technologies, Ltd. Israel
(16:40-17:00)
Coffee Break
(17:00-18:10)
COMPANY PRESENTATIONS AND PRIVATE CONSULTATIONS
With the Experts
Presenting Companies:
Vascure
Lartim
Cardioguard
InspireMD
Pluristem
Mazal Plant Pharmaceuticals, Inc.
(18:10-18:30)
CLOSING REMARKS
|
| 16:00-16:30 |
Coffee Break
Sponsored by Biosense |
| 16:30-18:30 |
Breakout Sessions |
| |
Company Presentations: MEDICAL DEVICE
MetaCure, Inc.
LifeBond, Ltd.
Nephera, Ltd.
CollPlant, Ltd.
Spatz FGIA, Inc.
Inca Medical Systems
|
Company Presentations:
BIOPHARMA
AIT-Applied Immune Technologies, Ltd.
Biokine Therapeutics, Ltd.
MaimonidexRA
BrainStorm Cell Therapeutics
BioLineRx
Galmed Medical Research, Ltd. |
Seminar: STEM CELLS
Moderator: Dr. Yael Margolin, CEO, Gamida-Cell, Israel
PERSPECTIVES OF REGENERATIVE MEDICINE FROM A LARGE PHARMA/DEVICE PERSPECTIVE. CAN'T LIVE WITH IT - CAN'T LIVE WITHOUT IT
Joseph F. Amaral, Vice President, Medical Devices & Diagnostics Emerging Technologies, Johnson & Johnson, USA
ISRAELI EXPERIENCE IN CELL THERAPY
Shosh Merchav, TEVA, Israel
CELLERIX EXPERIENCE AND LESSONS IN REGENERATIVE MEDICINEN
Eduardo Bravo, Cellerix
GAMIDA CELL PERSPECTIVE IN BONE MARROW TRANSPLANTATION
Dr. Yael Margolin, CEO, Gamida-Cell, Israel
MANUFACTURING OF A CELL BASED PRODUCT: HOW TO GET READY TO THE COMMERCIAL PHASE
Dr. Christian van den Bos, Executive Program Manager, LIFT, Lonza AG, Germany
MASS PRODUCTION OF CELL THERAPY PRODUCTS - A DREAM OR REALITY
Zami Aberman, Chairman & CEO, Pluristem, Israel
Panel Discussion:
Moderator: Dr. Aharon Schwartz, TEVA, Israel |
| 18:30-21:00 |
ILSI WELCOME RECEPTION |
|
| SATELLITE EVENT (By Invitation Only) |
| 12:00-14:00 |
|
David InterContinental Hotel | |
| TUESDAY, JUNE 15, 2010 |
|
(08:30 - 10:00) Breakfast Session
IMMINENT AND RECENT CHANGES IN USPTO POLICY AND US PATENT PRACTICE:
A PROPOSED RESPONSE FOR INVENTORS AND INVESTORS
Dr. Daniel Goldstein, Senior Patent Attorney, Sanford T. Colb & Co., Israel
(Pre registration required - limited seating) RSVP: scolb@kenes.com |
| 09:00-09:10 |
GREETINGS
Dr. Eli Opper
Chief Scientist, Ministry of Industry, Trade and Labor, Israel |
| 09:10-10:00 |
ALICE IN WONDERLAND: HOW TO NAVIGATE THE TOPSY TURVY WORLD OF BIOPHARMACEUTICAL DEVELOPMENT & COMMERICALIZATION
Moderator: Dr. Karen Bernstein, Chairman & Editor-in-Chief, BioCentury Publications Inc., USA
Panel Discussion:
Dr. Ron Cohen, President & CEO, Acorda Therapeutics, Inc., USA
Dr. Jeremy M. Levin, Senior Vice President, Strategy, Alliances and Transactions, Bristol Myers Squibb, USA
Paul Sekhri, Head, Biotech Ops Group, TPG Biotech/TPG Growth, LLC, USA
Jonathan Silverstein, General Partner, OrbiMed Advisors, LLC, USA |
| 10:00-10:50 |
Keynote Lecture: THE U.S. MEDICAL TECHNOLOGY INDUSTRY: CHALLENGES AND OPPORTUNITIES
Stephen Ubl, President & CEO, Advanced Medical Technology Association (Advamed), USA
(10:30-10:40) Interview by:
David Cassak, Elsevier, USA |
| 10:50-11:20 |
Coffee Break
Sponsored by Ktiva Biomedical |
| 11:20-13:20 |
Breakout Sessions |
| |
Company Presentations: MEDICAL DEVICE
Impulse Dynamics
Kyma Medical Technologies, Ltd.
EarlySense, Ltd.
Gardia Medical, Ltd.
dbMotion, Ltd.
OrSense, Ltd.
|
Company Presentations:
BIOPHARMA
Kamada, Ltd.
Protalix, Ltd.
BiondVax Pharmaceuticals, Ltd.
Dynamix Pharmaceuticals
Alcobra, Ltd.
Medgenics, Inc. |
Seminar: METABOLIC DISEASE
Moderator:
Barry Greene, President & Chief Operating Officer, Alnylam Pharmaceuticals, USA
Panel Discussion:
Barry Greene, President & Chief Operating Officer, Alnylam Pharmaceuticals, USA
Dr. Simeon I. Taylor, Vice President, Discovery Biology (Cardiovascular and Metabolic Diseases), Pharmaceutical Research Institute, Bristol-Myers Squibb Company, USA
Prof. Avraham Karasik, TEVA, Israel
Dr. Marc Reitman, Director, Clinical Research, Merck Research Laboratories, USA
Dr. Philip R. Schauer, Chief of Minimally Invasive General Surgery & Director, Bariatric & Metabolic Institute Cleveland Clinic |
Technology Transfer Session I: PHARMACEUTICALS AND STEM CELLS
Moderator: Dr. Sylvie Luria, Technology Transfer Officer, Sheba Medical Centre, Israel
Ramot at Tel Aviv University Ltd.
PEPTIDES AND CELL THERAPY - NOVEL THERAPEUTICS FOR DIABETES AND CNS RELATED DISEASES
Dr. Tamar Raz
Tel Aviv Souraski Medical Center
APPLYING A NOVEL MSF-A-HIF ALFA COMPLEX TO CANCER TREATMENT
Dr. Nicola J. Mabjeesh
Yeda R&D Co. Ltd, Weizmann Institute of Science
A UNIQUE IMMUNE-BASED THERAPY TO TREAT MENTAL DISORDERS
Dr. Shiraz Kalir
Hadasit Medical Research Services & Development Ltd. - The Technology Transfer Company of Hadassah University Hospitals
PREVENTION OF HUMAN INSULIN RESISTANCE AND DIABETES BY OPENING THE INSULIN SIGNALING PATHWAY THROUGH ABROGATION OF PKC EPSILON ACTIVITY
Dr. Einat Zisman
Tel Hashomer Medical Research, Infrastructure and Services Ltd. - Chaim Sheba Medical Center KLOTHO: FROM HORMONE TO NOVEL CANCER THERAPY
Dr. Ido Wolf
IDENTIFICATION AND PROSPECTIVE ISOLATION OF NOVEL HUMAN RENAL STEM/PROGENITOR POPULATIONS
Prof. Benjamin Dekel
B.G.Negev Technologies Ltd. - Technology Transfer Company of Ben-Gurion University
A NOVEL TREATMENT FOR ALS AND OTHER NEURODEGENERATIVE DISEASES
Prof. Esther Priel
Carmel, Haifa University Economic Corporation
IDENTIFICATION OF NATURAL ANTI-CANCER FACTORS AND CHARACTERIZATION OF THEIR MOLECULAR MECHANISM OF ACTION
Prof. Fuad Fares
BioRap Technologies Ltd. - The Technology Transfer Company of the Rappaport Research Institute, Technion
A ROLE FOR PLEXIN-A4 IN TUMOR PROGRESSION
Boaz Kigel
T3, Technion - Israel Institute of Technology
ENGINEERING VASCULARIZED PANCREATIC ISLETS IN-VITRO
Prof. Shulamit Levenberg
Bar-Ilan Research and Development Company, Ltd.
CAN ONE MAKE A NUCLEOTIDE-BASED DRUG? MAKING THE IMPOSSIBLE POSSIBLE
Prof. Bilha Fischer |
Seminar: E-VOLVING PROMISES OF EFFICIENCY AND EMPOWERMENT IN HEALTHCARE
Moderator: Tamar Howson, JSB Partners, USA
Panel Discussion:
William J. Febbo, CEO, MedPanel, USA
Nitzan Sneh, CEO, CliniWorks, Inc., USA
Richard Young, Area Sales Director, Medidata Solutions, Inc, UK |
| 13:20-14:20 |
Lunch Break |
(12:00 – 14:00) Lunch Session
THE STRATEGIC VALUE OF IP IN THE NEW LIFE SCIENCE ECONOMY
Dr. Kfir Luzzatto, Senior Partner, Luzzatto & Luzzatto Patent Attorneys
(Pre registration required - limited seating) RSVP: zizib@luzzatto.co.il |
| 14:20-15:10 |
Keynote Lecture: A SMARTER HEALTHCARE SYSTEM, A CATALYST FOR INNOVATION
Katherine C. Holland, IBM General Manager, Global Life Sciences Industry, USA |
| 15:10-16:00 |
Keynote Lecture: HEALTHCARE MARKET AND REGULATORY CHANGE IN THE US
Dan Mendelson, President & Founder, Avalere Health LLC, USA |
| 16:00-16:30 |
Coffee Break |
| 16:30-18:30 |
Breakout Sessions |
| |
Company Presentations: MEDICAL DEVICE
BioControl Medical (B.C.M), Ltd.
RealView Medical, Ltd.
Beta-Stim, Ltd.
Medi-Tate, Ltd.
ElMindA, Ltd.
P-Cure, Ltd. |
Company Presentations:
BIOPHARMA
Chiasma
Vaxil Biotherapeutics, Ltd.
Prolor-Biotech, Inc.
Foamix, Ltd.
Sol-Gel Technologies, Ltd.
CartiCure, Ltd. |
Seminar: PERSPECTIVES ON PERSONALIZED MEDICINE
Moderator: Dr. Edward Abrahams, Executive Director, Personalized Medicine Coalition, USA
Panel Discussion:
Dr. Robert S. Epstein, Chief Medical Officer & President, Medco Research Institute, Medco Health Solutions, Inc., USA
Dr. Rowan Chapman, Mohr Davidow Ventures, USA
Dr. Stephen L. Eck, Vice President, Translational Medicine & Pharmacogenomics, Eli Lilly & Company, USA
|
Technology Transfer Session II: MEDICAL DEVICES & BIOLOGICAL TOOLS
Moderator: Mr. Benjamin Soffer, Technion - Israel Institute of Technology
Yissum- The Technology Transfer Company of the Hebrew University of Jerusalem
NOVEL BIOMEDICAL POLYMERS AND MEDICAL DEVICES
Prof. Daniel Cohn
SUPERFAST DRUG DISCOVERY IN SILICO
Prof. Amiram Goldblum
Tel Aviv Souraski Medical Center
GUIDED REGENERATION GEL AS A STAND ALONE PRODUCT WITH GROWTH PERMISSIVE FOR MULTI PURPOSES
Dr. Shimon Rochkind
Bar-Ilan Research & Development Company, Ltd.
MULTI-FUNCTIONAL BIO-MEDICAL MICROPROBE
Prof. Zeev Zalevsky
T3, Technion - Israel Institute of Technology
COMPACT MAGNETIC RESONANCE PROBES FOR MEDICAL APPLICATIONS
Prof. Aharon Blank
Tel Hashomer Medical Research, Infrastructure & Services Ltd. - Chaim Sheba Medical Center
ROBOPILL - A NOVEL GUIDED INGESTIBLE DEVICE FOR THE GATROINTESTINAL TRACT
Dr. Shomron Ben-Horin
Yeda R&D Co. Ltd. - Weizmann Institute of Science
GYNECOLOGICAL ENDOSOPIC PHOTODYNAMIC THERAPY (GEPT)
Shay Marcus
Fund for Medical Research Development of Infrastructure & Health Services - Rambam Medical Center
A VASCULAR BOOSTER ASSIST DEVICE FOR CRITICAL LIMB ISCHEMIA
Prof. Aaron Hoffman
BLOOD DERIVED ENDOTHELIAL PROGENITOR CELLS FOR BONE REGENERATION
Dina Lewinson
FUNCTIONAL RESIDUAL CAPACITY MEASUREMENT IN MECHANICALLY VENTILATED PATIENTS
Yaron Bar-Lavie
Mor Research Applications - Clalit Health Services
NOVEL THERAPEUTIC SYSTEM TO TREAT OSTEOARTHRITIS & AGED SKIN
Dr Talia Weinstein |
C-Trials: WHEN SAFETY MEETS REGULATION
(16:20-17:20)
FDA REQUIREMENTS FOR CLINICAL PRACTICE
How to meet the US submission Standards in:
• Trials conducted outside the US
• Combination products
Dr. Barbara S. Fant, President & CEO, Clinical Research Consultants, Inc., USA
(17:20-18:20)
EMEA SAFETY REQUIREMENTS
From Clinical trials to Marketing Authorization
• Risk Management Plan
• EU Pharmacovigilance System
• Advanced Therapies
Dr. Irene Fermont, Vice President, Pharmacovigilance & Risk Management, Advanced Drug Development Services SAS, France |
| |
| SATELLITE EVENTS (Pre-registration required - limited seating) |
|
12:00-14:00 |
|
Dan Panorama Hotel |
|
16:00-18:00 |
|
David InterContinental Hotel | |
| WEDNESDAY, JUNE 16, 2010 |
| 09:00-09:50 |
Keynote Lecture: NANOTECHNOLOGY ENABLES INDIVIDUALIZED MEDICINE
Prof. Mauro Ferrari, Professor & Chairman, Department of Nanomedicine & Biomedical Engineering (nBME), Professor of Internal Medicine, Division of Cardiology, University of Texas Health Science Center, USA
(09:40-09:50) Interview by:
David Cassak, Elsevier, USA |
| 09:50-10:40 |
Keynote Lecture: THE GOLDEN AGE OF INNOVATION: BEHIND OR AHEAD OF US?
Dr. Harlan F. Weisman, Chief Science and Technology Officer, Medical Devices & Diagnostics, Johnson & Johnson, USA
(10:30-10:40) Interview by:
David Cassak, Elsevier, USA |
| 10:40-11:10 |
Coffee Break
Sponsored by Johnson & Johnson |
| 11:10-13:10 |
Breakout Sessions |
| |
Company Presentations:
MEDICAL DEVICE
InsuLine Medical
NanoVibronix
GI View, Ltd.
Moebius Medical, Ltd.
Discover Medical Devices, Ltd.
Exalenz Bioscience, Ltd.
|
Company Presentations:
BIOPHARMA
MacroCure, Ltd.
TransPharma Medical
Oramed Pharmaceuticals
D-Pharm, Ltd.
Can-Fite BioPharma, Ltd.
BioCancell Therapeutics, Inc. |
Seminar: ONCOLOGY
Moderator: Dr. Rachel Humphrey, Vice President of Development, Bristol-Myers Squibb, USA
Panel Discussion:
Dr. David P. Schenkein, CEO, Agios Pharmaceuticals, USA
Prof. Dror Harats, CEO, Vascular Biogenics Ltd., Israel
Dr. Laurence Kennedy, Chairman of Endocrinology, Diabetes and Metabolism Department, Cleveland Clinic, USA
Dr. Elon Kirson, Chief Medical Officer, NovoCure, Israel |
Technology Transfer Session III: DRUG DELIVERY & MOLECULAR MARKERS
Moderator: Amir Naiberg, Weizmann Institute of Science
Ramot at Tel Aviv University Ltd.
NOVEL DRUG DELIVERY TECHNOLOGIES TARGETING ONCOLOGY, INFECTIOUS AND INFLAMMATORY-RELATED DISEASES
Irit Ben Chlouch
B.G.Negev Technologies Ltd. - Technology Transfer Company of Ben-Gurion University
DELIVERY OF PEPTIDES, siRNA AND GROWTH FACTORS USING NOVREL DELIVERY SYSTEMS
Dr. Ora Horovitz
Yissum - The Technology Transfer Company of the Hebrew University of Jerusalem
CLINICAL IMPLICATIONS OF A NOVEL BIOMARKER FOR EVALUATING THE IMMUNE FUNCTIONAL STATUS UNDER NORMAL AND PATHOLOGICAL CONDITIONS
Prof. Michal Baniyash
Tel Aviv Souraski Medical Center
A NOVEL DRUG DELIVERY FOR THE TREATMENT OF BRAIN DISEASES
Prof. Naftalie Stern
Yeda R&D Co. Ltd. - Weizmann Institute of Science
A TOOL FOR THE DIAGNOSIS AND MONITORING OF SCHIZOPHRENIA
Dr. Ruth Ben-Yakar
Hadasit Medical Research Services & Development Ltd. - The Technology Transfer Company of Hadassah University Hospitals
CCAT-1 AS A NOVEL MOLECULAR MARKER FOR COLORECTAL CANCER
Dr. Einat Zisman
Mor Research Applications - Clalit Health Services
ANTIBODY-BASED THERAPY OF HUMAN TUMORS TARGETING L1CAM BIOMARKER
Prof. Mina Fogel
Carmel, Haifa University Economic Corporation
THE CENTER FOR GENE MANIPULATION IN THE BRAIN
Dr. Efrat Edry
BioRap Technologies Ltd. - The Technology Transfer Company of the Rappaport Research Institute, Technion
AUTOANTIBODY BASED DIAGNOSIS OF CANCER AND AUTOIMMUNITY
Prof. Natan Karin |
Seminar: EUROPEAN MARKETS: REGULATION & REIMBURSEMENT REQUIREMENTS FOR MEDICAL DEVICES & BIOPHARMA
EU LEGISLATION FOR ONCOLOGY DRUGS: FROM RESEARCH TO MARKET
Béatrice Janin Jacquat, Medical Director, Includeconsulting, Switzerland
REIMBURSEMENT OF MEDICAL DEVICES IN EUROPE - ONE CRITICAL FACTOR FOR PRODUCT VALUE APPRAISAL
Dr. Hubertus Rosery, President & CEO, AiM GmbH, Germany
IS INNOVATION IN CANCER TREATMENTS ACCESSIBLE FOR THE KEY 5 EUROPEAN MARKETS?
Maie N. Gall, Management Consultant, Matems Consulting Ltd., Switzerland
CLINICAL EVALUATION - A NOTIFIED BODIES PERSPECTIVE
Robert van Boxtel, Sr. Project Manager Certification Medical Devices, Kema Quality B.V., The Netherlands |
| 13:10-14:10 |
Lunch Break |
(12:00-14:00) Lunch Session
FDA REGULATION OF MEDICAL DEVICES: LATEST DEVELOPMENTS AND THEIR IMPACT ON THE DEVICE INDUSTRY
Jonathan S. Kahan, Partner, Hogan Lovells
Dr. John J. Smith, Partner, Hogan Lovells
(Pre registration required - limited seating)
RSVP: neena.oduro@hoganlovells.com |
| 14:10-15:10 |
Closing Session: MEDICAL INNOVATION AND US HEALTHCARE REFORM - IN CONCERT OR AT ODDS?
Moderator: Debra L. Lappin, President, Council for American Medical Innovation, USA
Panel Discussion:
Jennifer Bryant, Deputy Vice President, Pharmaceutical Research & Manufacturers of America (PhRMA), USA
Dr. E. Cartier Esham, Director, Emerging Companies Health & Regulatory Affairs, Biotechnology Industry Organization (BIO), USA
Ralph Ives, Executive Vice President, Global Strategy & Analysis, Advanced Medical Technology Association (Advamed), USA
Chris Coburn, Vice-Chair, Executive Director, Cleveland Clinic Innovations, USA
Ruben Krupik, CEO, Clal Biotechnology Industries, Israel | |
|
|
Media Partner |
Official News Distribution Service’ |
  |
 |
|
|
|
|
|